I've heard Michael McCaughan talk a few months ago in an E&Y conference and he sounded quite intelligent, but he wasn't talking about Teva’s strategy then.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.